Author
Listed:
- Mercy Itohan Aboh
(National Institute for Pharmaceutical Research and Development, Abuja, Federal Capital Territory)
- Okefu Oyale Okoko
(National Malaria Elimination Program (NMEP), Abuja)
- Oluwatoyin Basirat Karimu
(National Malaria Elimination Program (NMEP), Abuja)
- Ezire Onoriode
(The World Bank Group, Abuja)
- Obi Peter Adigwe
(National Institute for Pharmaceutical Research and Development, Abuja, Federal Capital Territory)
Abstract
Introduction: To catalyse local manufacturing and reduce costs, Nigeria’s Zero-Tariff Executive Order for critical pharmaceutical inputs was promulgated as a strategic instrument to advance national medicines’ security. Whilst the policy is strategically positioned to deliver transformative benefits, empirical evidence on its early implementation and stakeholder experiences remains scarce. This study provides context specific insights into stakeholder awareness, experiences, and systemic constraints, offering evidence-based recommendations to ensure the policy delivers its intended national impact. Methods: A qualitative design was employed to elicit in-depth insights from selected stakeholders within pharma companies identified to benefit from the initiative. Semi-structured interviews explored critical thematic areas. The study cohort comprised industry representatives and other relevant experts in the manufacturing industry. Data were transcribed verbatim and analysed thematically to yield overarching themes and sub-themes, with trustworthiness ensured through triangulation and CASP checklist application. Results: The analysis revealed widespread awareness of the Order but highlighted the need for robust communication for experts who are unaware. Participants also indicated access to modest cost relief where exemptions were processed efficiently, whilst many eligible actors did not operationalise benefits. With regard to barriers, three key themes emerged from this study. These comprised regulatory and customs barriers, financial and economic pressures, and policy timeline and scope limitations. Stakeholders also put forward actionable recommendations, including extending the Order’s duration, periodically reviewing the exempted product list, harmonising HS codes, reforming customs and regulatory processes with transparent protocols, and establishing a multi-agency taskforce, among others. Conclusion: In conclusion, urgent operational reforms and supportive policy measures are required to convert policy intent into measurable gains for local manufacturing, affordability and access.
Suggested Citation
Mercy Itohan Aboh & Okefu Oyale Okoko & Oluwatoyin Basirat Karimu & Ezire Onoriode & Obi Peter Adigwe, 2026.
"From Policy to Practice: A Qualitative Exploration of Stakeholders’ Awareness and Experiences with the Implementation of the Zero-Tariff Executive Order on Critical Pharmaceutical Inputs,"
International Journal of Research and Scientific Innovation, International Journal of Research and Scientific Innovation (IJRSI), vol. 13(2), pages 1444-1456, February.
Handle:
RePEc:bjc:journl:v:13:y:2026:i:2:p:1444-1456
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bjc:journl:v:13:y:2026:i:2:p:1444-1456. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Dr. Renu Malsaria (email available below). General contact details of provider: https://rsisinternational.org/journals/ijrsi/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.